Copertina

Medication utilization and lung function changes after initiation of treatment with elexacaftor/tezacaftor/ivacaftor

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Richard De Vuyst, Charissa W. Kam, Cameron J. McKinzie, Charles R. Esther
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Pediatric Pulmonology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Severe mental health changes in patients with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor therapy
di: Cameron J. McKinzie, et al.
Pubblicazione: (2024)

Disparities in elexacaftor/tezacaftor/ivacaftor initiation in the US cystic fibrosis population
di: Kamyron Jordan, et al.
Pubblicazione: (2024)

Mental health, sleep, and respiratory health after initiating elexacaftor/tezacaftor/ivacaftor treatment in children with cystic fibrosis
di: Hiep Pham, et al.
Pubblicazione: (2024)

Current State of Pharmacogenomic Implementation Into Care for Persons With Cystic Fibrosis
di: Emma M. Tillman, et al.
Pubblicazione: (2025)

Diagnosis and treatment of ADHD in pediatric patients during the first year of elexacaftor/tezacaftor/ivacaftor
di: Kimberly Pasley, et al.
Pubblicazione: (2024)

A survey of cystic fibrosis physicians' views on lung transplant referral in the era of elexacaftor/tezacaftor/ivacaftor
di: Nora Burdis, et al.
Pubblicazione: (2024)

Clinical effectiveness of elexacaftor/tezacaftor/ivacaftor in a man with A559T and 3120+1G>CFTR variants
di: Emily Mitchell, et al.
Pubblicazione: (2024)

Effectiveness and safety of elexacaftor/tezacaftor/ivacaftor treatment in children aged 6‐11 years with cystic fibrosis in a real‐world setting
di: Valeria Daccò, et al.
Pubblicazione: (2024)

Impact of Elexacaftor/Tezacaftor/Ivacaftor on Microbiology and Antibiotic Utilization in People With Cystic Fibrosis
di: Cindy L. Williams, et al.
Pubblicazione: (2025)

Papilledema in Children With Cystic Fibrosis Receiving Elexacaftor/Tezacaftor/Ivacaftor: A Multicenter Case Series
di: Charissa W. Kam, et al.
Pubblicazione: (2024)

Clinical evidence of pancreatic recovery in children with cystic fibrosis on ivacaftor
di: Sydney Walker, et al.
Pubblicazione: (2024)

Diagnosis of interstitial lung disease after surgery in an adolescent
di: Fazılcan Zirek, et al.
Pubblicazione: (2024)

Incidence, prevalence, and pattern of medical service utilization of children's rare lung diseases in South Korea
di: Hwan Soo Kim, et al.
Pubblicazione: (2024)

Childhood CBD exposure and lung function: Concerns and future directions
di: Lien‐Chung Wei, et al.
Pubblicazione: (2024)

Childhood exposure to cannabidiol and lung function: A pilot study
di: Nolan Younoszai, et al.
Pubblicazione: (2024)

The SMART approach improves rehabilitation adherence after lung transplantation in pediatric intensive care unit
di: Hisataka Nozawa, et al.
Pubblicazione: (2024)

Air pollution exposure during pregnancy and lung function in childhood: The LUIS study
di: Jakob Usemann, et al.
Pubblicazione: (2024)

Commentary on “breathing breakthrough: Muscle training improves lung function in juvenile arthritis”
di: Payal Mehta, et al.
Pubblicazione: (2024)

Atypical presentation of primary lung abscess in an infant
di: Katherine Briski, et al.
Pubblicazione: (2024)

Impaired lung function in infants with primary ciliary dyskinesia: A pilot Czech study
di: Václav Koucký, et al.
Pubblicazione: (2024)

Treatment of small as well as large declines in lung function enhances recovery to baseline in people with CF
di: Michael S. Schechter, et al.
Pubblicazione: (2024)

The utility of elective flexible bronchoscopy to improve quality of life and clinical outcomes for children: A systematic review
di: Rahul J. Thomas, et al.
Pubblicazione: (2024)

Lung clearance index (LCI2.5) changes after initiation of Elexacaftor/Tezacaftor/Ivacaftor in children with cystic fibrosis aged between 6 and 11 years: The “real‐world” differs from trial data
di: Don S. Urquhart, et al.
Pubblicazione: (2024)

Pediatric lung ultrasound
di: Ioana Ciuca
Pubblicazione: (2024)

Lung T1 MRI assessments in children with mild cystic fibrosis lung disease
di: Clement L. Ren, et al.
Pubblicazione: (2024)

A left‐sided destroyed lung in a 11‐year‐old girl: A rare sequela after Mycoplasma pneumoniae infection
di: Maoyi Zuo, et al.
Pubblicazione: (2024)

PM2.5 exposure and household income are associated with lung function abnormalities in children with sickle cell disease
di: Jelte Kelchtermans, et al.
Pubblicazione: (2024)

Long‐term lung function follow‐up of preterm infants less than 32 weeks of gestational age
di: Amaia Merino‐Hernández, et al.
Pubblicazione: (2024)

The lung in inborn errors of immunity
di: Sonia Restrepo‐Gualteros, et al.
Pubblicazione: (2024)

Fibrotic lung diseases in children
di: Birce Sunman, et al.
Pubblicazione: (2024)

Social determinants of health and somatic growth in preterm infants and children with chronic lung disease
di: Brianna C. Aoyama, et al.
Pubblicazione: (2024)

Nebulized granulocyte macrophage‐colony stimulating factor to stabilize lung function in nontuberculous mycobacteria pulmonary disease in cystic fibrosis
di: Colette Biro, et al.
Pubblicazione: (2024)

Serpentine pulmonary arteries supplying the lung isthmus in horseshoe lung: A rare cause of esophageal compression
di: Pratyaksha Rana, et al.
Pubblicazione: (2024)

Postnatal chest X‐ray in children with asymptomatic congenital lung malformations
di: Louis W. J. Dossche, et al.
Pubblicazione: (2024)

Dangers of under‐treatment and over‐treatment with inhaled corticosteroids in children with asthma
di: Breanne Hayes, et al.
Pubblicazione: (2024)

Recent progress in neonatal hyperoxic lung injury
di: Tian Rao, et al.
Pubblicazione: (2024)

When lungs and weights tell different stories
di: Sanjiv Godse, et al.
Pubblicazione: (2024)

Abnormal bronchial origin in the right middle and lower lung
di: Hao‐bo Chen, et al.
Pubblicazione: (2024)

Striving for healthy lungs: Enhancing respiratory outcomes of prematurity
di: Amir Kugelman
Pubblicazione: (2024)

Interstitial lung disease in infancy and early childhood: Clinical approach
di: Andrew Bush
Pubblicazione: (2024)